This Wednesday will mark 12 years since the Affordable Care Act was signed into law and cancer patients, survivors and millions of others gained expanded access to comprehensive health coverage.
Tobacco use rates among US adults hit an all-time low, but rates remain high among certain populations according to data released by the Centers for Disease Control and Prevention today.
The cost of cancer care is substantially impacting the lives of cancer patients and survivors, forcing them to make significant lifestyle changes, and causing some to incur long-term medical debt.
A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds youth tobacco use remains a serious public health threat.
Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.
Los defensores están presionando al Congreso para que aumente el financiamiento de la investigación del cáncer en los Institutos Nacionales de la Salud (NIH), el Instituto Nacional del Cáncer (NCI) y para que financie la propuesta del presidente de crear el Proyecto de Investigación Avanzada sobre la Salud (ARPA-H) como parte del presupuesto federal del año fiscal 2022.
The Food and Drug Administration (FDA) today authorized the marketing of two low-nicotine cigarettes as “modified risk tobacco products,” including one product that is menthol-flavored.
La Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer está celebrando el 50º aniversario de la promulgación de la Ley Nacional del Cáncer por parte del presidente Richard Nixon. La ley, que entró en vigencia el 23 de diciembre de 1971, transformó el enfoque de la nación para prevenir, detectar y tratar la enfermedad.
The majority of cancer patients in the United States say they struggle to afford the costs of their cancer care.
The U.S. Food and Drug Administration (FDA) opposed public health groups’ request that the agency provide regular status reports to a U.S. District Judge and estimate the dates it expects to complete its review of applications for products that rank among the top 10 brands in market share.